Ads
related to: cancer, herceptin- Downloadable Resources
Access ENHERTU Downloadable
Resources For Your Patients.
- Efficacy & Safety Data
Learn More About The
Efficacy & Safety Data For ENHERTU.
- ENHERTU Dosing
Find ENHERTU Dosing & Admin
Resources For Your Practice.
- ENHERTU Information
Visit To Learn More About
ENHERTU For Your Practice.
- Watch MOA Videos
Watch Mechanism Of Action Videos
For ENHERTU. HCP Site.
- ENHERTU Resources
Find Helpful ENHERTU Resources
For Your Practice.
- Downloadable Resources
Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoIt will be historic when it is no longer the first prescribed agent in HER2+ mBC and Enhertu may...
UCLA oncologist Dr. Dennis Slamon awarded Szent-Gy | Newswise
Newswise· 3 days agoDr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 4 days agoARX788 is attempting to enter a crowded field, Enhertu (trastuzumab deruxtecan) is the standard of...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via Yahoo News· 6 days ago(Reuters) -AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 18 hours agoA New Top Biotech Stock Corcept Therapeutics is a newer addition to the list of leading biotech...
ASCO: Jazz shares 'unprecedented' HER2 biliary tract cancer data ahead of FDA decision
FierceBiotech· 7 days agoAs zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoEvorpacept in combination with PADCEV®, an approved antibody-drug conjugate (“ADC”), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with Samuel A. Funt, M.D., of Memorial Sloan Kettering
Top Analyst Reports for Roche, Wells Fargo & GE Aerospace
Zacks via Yahoo Finance· 4 days agoToday's Research Daily features new research reports on 16 major stocks, including Roche Holding AG...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 4 days agoIn 2024, Teva expects Uzedy sales of approximately $80 million. Teva markets biosimilar versions of...
Ads
related to: cancer, herceptin
